Morgan Stanley
-
-
-
-
-
-
-
Morgan Stanley Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
After-hours movers: First Republic resumes free-fall despite lifeline, FedEx surges on raised guidance
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/13: (WTRH) (KOSS) (RVNC) Higher; (RGLS) (ARDX) (STIM) Lower (more...)
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Downgrades Sarepta Therapeutics (SRPT) to Equalweight
-
-
-
-
-
-
-
Pre-Open Movers 10/04: (AVYA) (RNG) (SRPT) Higher; (ABUX) (ASNA) (HPQ) Lower (more...)
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) to Offer $350M in Common Stock
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Raised to $91 at Morgan Stanley
-
227,298 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

